# Nemours Alfred I. duPont Hospital for Children – FDA Inspection, Mar 31, 2016

Source: https://www.keypedia.com/records/fda_inspections/nemours-alfred-i-dupont-hospital-for-children/1ad69c54-0033-4a92-8f1f-78ba00709c2f
Source feed: FDA_Inspections

> FDA inspection 967915 of Nemours Alfred I. duPont Hospital for Children, March 31, 2016. Classification: No Action Indicated (NAI). 5 other FDA inspections on record for this company.

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 967915
- Company Name: Nemours Alfred I. duPont Hospital for Children
- Inspection Date: 2016-03-31
- Classification: No Action Indicated (NAI)
- Classification Code: NAI
- Project Area: Blood and Blood Products
- Product Type: Biologics
- Center: Biologics
- Office Name: Center for Biologics Evaluation and Research
- Citation Count: 0

## Related Documents

- [FDA Inspection 1280525 - 2025-08-21](https://www.keypedia.com/records/fda_inspections/nemours-alfred-i-dupont-hospital-for-children/80140d6c-7b38-43e8-84de-63129d553e6b)
- FDA Inspection 1069118 - 2018-09-17
- FDA Inspection 874287 - 2014-04-15
- FDA Inspection 776372 - 2012-04-05
- FDA Inspection 669286 - 2010-06-28

Company: https://www.keypedia.com/companies/nemours-alfred-i-dupont-hospital-for-children/fefd4e17-c707-48c1-9d64-984f34ee8fb1

Office: https://www.keypedia.com/offices/center-for-biologics-evaluation-and-research/dd9e8ea7-6f04-4ed1-b0d7-e7e6b264570d
